Evidence map›Paper›PMID 29712924›Full record

ArticleScientific reports2018

Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages.

Sugata Roy, Sebastian Schmeier, Bogumil Kaczkowski, Erik Arner, Tanvir Alam, Mumin Ozturk, Ousman Tamgue, Suraj P Parihar, Hideya Kawaji, Masayoshi Itoh and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Epigenetic Mechanisms Induced byInternational journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Genome-wide screen identifies host loci that modulatebioRxiv : the preprint server for biology · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. microLife · 2023
    Article
  19. Antibiotic Resistance toAntibiotics (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 6 countries.

Sugata RoyDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Sebastian SchmeierMassey University, Institute of Natural and Mathematical Sciences, Auckland, New Zealand.ORCID 0000-0002-3947-8226
Bogumil KaczkowskiDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.ORCID 0000-0001-6554-5608
Erik ArnerDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Tanvir AlamKing Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Computer, Electrical and Mathematical Sciences and Engineering Division (CEMSE), Thuwal, Saudi Arabia.ORCID 0000-0003-4844-0171
Mumin OzturkInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component, Cape Town, 7925, South Africa.ORCID 0000-0001-9152-7614
Ousman TamgueInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component, Cape Town, 7925, South Africa.
Suraj P PariharInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component, Cape Town, 7925, South Africa.
Hideya KawajiDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.ORCID 0000-0002-0575-0308
Masayoshi ItohDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Timo LassmannDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Piero CarninciDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Yoshihide HayashizakiRiken Omics Science Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Alistair R R ForrestDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Reto GulerInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component, Cape Town, 7925, South Africa.
Vladimir B BajicKing Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Computer, Electrical and Mathematical Sciences and Engineering Division (CEMSE), Thuwal, Saudi Arabia.ORCID 0000-0001-5435-4750
Frank BrombacherInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component, Cape Town, 7925, South Africa. frank.brombacher@icgeb.org.
Harukazu SuzukiDivision of Genomic Technologies, RIKEN Center for Life Science Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan. harukazu@gsc.riken.jp.
South African Medical Research Council · ZARIKEN Advanced Science Institute · JPRIKEN Center for Integrative Medical Sciences · JPKing Abdullah University of Science and Technology · SAMassey University · NZRIKEN Center for Sustainable Resource Science · JPThe Kids Research Institute Australia · AU

Funding

Wellcome TrustWellcome Trust 203135Z/16/Z
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) infection reveals complex and dynamic host-pathogen interactions, leading to host protection or pathogenesis. Using a unique transcriptome technology (CAGE), we investigated the promoter-based transcriptional landscape of IFNγ (M1) or IL-4/IL-13 (M2) stimulated macrophages during Mtb infection in a time-kinetic manner. Mtb infection widely and drastically altered macrophage-specific gene expression, which is far larger than that of M1 or M2 activations. Gene Ontology enrichment analysis for Mtb-induced differentially expressed genes revealed various terms, related to host-protection and inflammation, enriched in up-regulated genes. On the other hand, terms related to dis-regulation of cellular functions were enriched in down-regulated genes. Differential expression analysis revealed known as well as novel transcription factor genes in Mtb infection, many of them significantly down-regulated. IFNγ or IL-4/IL-13 pre-stimulation induce additional differentially expressed genes in Mtb-infected macrophages. Cluster analysis uncovered significant numbers, prolonging their expressional changes. Furthermore, Mtb infection augmented cytokine-mediated M1 and M2 pre-activations. In addition, we identified unique transcriptional features of Mtb-mediated differentially expressed lncRNAs. In summary we provide a comprehensive in depth gene expression/regulation profile in Mtb-infected macrophages, an important step forward for a better understanding of host-pathogen interaction dynamics in Mtb infection.

Indexed as

Transcription, GeneticGene Expression Regulation, BacterialHost-Pathogen InteractionsHumansInterferon-gammaInterleukin-13Interleukin-4MacrophagesMycobacterium tuberculosisPromoter Regions, GeneticRNA, Long NoncodingTranscriptomeTuberculosisIFNG protein, humanInterferon-gammaInterleukin-13Interleukin-4RNA, Long Noncoding

Identifiers

PMID29712924
PMCPMC5928056
OpenAlexW2806918138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.